about
Application of radiation technology in vaccines developmentSearching for the human genetic factors standing in the way of universally effective vaccinesThe role of vaccination in preventing pneumococcal disease in adultsSurvey of vaccine distribution and delivery issues in the USA: from pediatrics to pandemics.Immunization of hematopoietic stem cell transplant recipients against vaccine-preventable diseases.The overall safety profile of currently available vaccines directed against infectious diseases."Negative vaccination" by specific CD4 T cell tolerisation enhances virus-specific protective antibody responsesPneumococcal meningitis: clinical outcomes in a pre-vaccine era at a Dublin paediatric hospital, 1999-2007.Immunotypes of a quaternary site of HIV-1 vulnerability and their recognition by antibodiesImmunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trial.Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomesPseudomonal infection in cystic fibrosis: the battle continues.Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus.Mucosal adjuvant properties of the Shigella invasin complexUnderstanding vaccines: a public imperative.IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safetyInfluenza-related hospitalization and ED visits in children less than 5 years: 2000-2011.Alphavirus vectors and vaccination.Childhood immunization controversies: what are parents asking?Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in MexicoPrinciples of tumor immunosurveillance and implications for immunotherapy.Progress towards achieving new vaccine and vaccination goals.The effect of zinc sulfate on immunologic response to recombinant hepatitis B vaccine in elderly: Zinc sulfate and immunologic response to recombinant hepatitis B vaccineProgress in the development of an HIV vaccine.Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantationNCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivorsDEC205-DC targeted DNA vaccines to CX3CR1 and CCL2 are potent and limit macrophage migration.Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants.Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label study.Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adultsCharacteristics Peripheral Blood IgG and IgM Heavy Chain Complementarity Determining Region 3 Repertoire before and after Immunization with Recombinant HBV Vaccine.Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.Burkholderia vaccines: are we moving forward?Gene vaccination for the induction of immune tolerance.Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults: a randomized opeInfluence of dose and frequency of antigen injection on IgE development in young children: a comparison of fire ant stings and tetanus immunizations.Return of inactivated whole-virus vaccine for superior efficacy.Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective.
P2860
Q26798165-487D7E91-175C-495E-A87C-DB483EEE608FQ27007034-88FBB5A6-236E-472D-92A3-28FF398B71A6Q28396749-A6937D65-E761-4737-8FBE-750C97A3D2D7Q30368555-FE5A6D73-DD71-4C8B-BB2D-3D444A738BF2Q30401036-BF4D5683-689C-4A82-A777-73A8B0AFBBC0Q33149223-0F8D159E-2F63-4B98-A09E-CCB30C53DD75Q33305432-50953FA3-A5A9-4AF9-80BE-4E3C015F8CB0Q33745369-A1246B23-0CCE-4369-88DC-AB1214BCAB55Q34164923-01C3EA50-147D-4606-86CE-4BBED0C26CCCQ34291076-F361D300-C449-4CDE-BB7A-03B6BCE01A25Q34329494-EA2B582C-61CF-43BB-9C97-AD7D6BC3E920Q34358536-1EF94201-6D7C-4EBE-B999-FC1D8C2D7002Q34416470-117B8971-7624-42EF-BA70-7711A975ED4CQ34601845-E56733B5-728E-473E-A24F-DE56550137C6Q34637490-CB30CB15-D675-4384-B7ED-95F4859F8DA2Q34723422-543C94F2-F024-4074-B332-A9D49A27C01CQ34785408-CC17897E-6BBE-4D99-8125-9A1A20098D60Q34812016-23DA250B-DFAE-43BB-92B6-D8E04AAEBE98Q34986582-C3829163-436E-4ECE-92EB-4B7427DBD8F0Q35021112-D4F76322-E2CF-4B14-AB9F-3A7CA8E20334Q35043113-0E8C51F3-C357-490F-BAC5-6B07BB780086Q35161394-6B4B19F8-5CA2-42A1-930A-7E40BBDCA0CAQ35507121-49CB4B60-E592-4D90-B696-93F9A23732BFQ35581128-79DE5906-B2CC-4F35-8B19-EF6BD1D154F1Q35613207-44E549DD-1A00-4E3D-AD5B-12C393CC6FFBQ35661304-8CD52844-657E-4072-B1B2-680DF579AF4CQ35738533-8FF0FF71-0ECA-4209-9969-4C1303185231Q35849178-FF807629-D3DF-4986-8033-8C83371DD2CCQ35855959-52B937F9-A8DB-48D9-A577-565822E677B7Q36126206-E1BB0558-0102-4713-BD62-D1354963476CQ36255837-1713F931-AC3D-4B23-B0F2-64ADFC2370FBQ36257451-DA8B90B3-E8FB-4A46-BD01-3115AEE92CD5Q36261750-5FF57991-7624-450A-B43C-FFE86FD1B974Q36370290-312EC05A-B01B-4111-8805-48097E45BD42Q36587103-B9016C5A-E6DA-4782-BA1C-CBA96E6DB967Q36958305-3FDB484B-25F7-4903-A719-CC2041D45D45Q36977893-2DAC6787-4A5B-479E-A393-810E450C2673Q37642543-A7BB5E13-5D57-4F12-B351-4A5983EE6043Q37918307-DEA80248-8224-4FF2-B203-1D83D5B37F66Q38066148-B594D772-42CD-442C-82C1-EA47A5746A3C
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Vaccines and vaccination.
@ast
Vaccines and vaccination.
@en
Vaccines and vaccination.
@nl
type
label
Vaccines and vaccination.
@ast
Vaccines and vaccination.
@en
Vaccines and vaccination.
@nl
prefLabel
Vaccines and vaccination.
@ast
Vaccines and vaccination.
@en
Vaccines and vaccination.
@nl
P356
P1476
Vaccines and vaccination.
@en
P2093
P304
P356
10.1056/NEJMRA011223
P407
P577
2001-10-01T00:00:00Z